The New England Journal of Medicine | Patient Daily

The New England Journal of Medicine

Bob Pepalis | Jun 3, 2020

Flawed data puts COVID-19 policies, treatments in doubt

Amanda Rupp | May 16, 2016

Takeda Pharmaceutical publishes Ninlaro trial results

Trending

+ Pharmaceuticals

Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'

+ Pharmaceuticals

Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’

+ Pharmaceuticals

Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’